chloroquine has been researched along with dextrothyroxine in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (9.52) | 18.7374 |
| 1990's | 1 (4.76) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (4.76) | 24.3611 |
| 2020's | 17 (80.95) | 2.80 |
| Authors | Studies |
|---|---|
| Breckenridge, A; Edwards, G; Orme, M | 1 |
| Belot, J; Bornarel, P; Pangui, LJ | 1 |
| Mak, JW; Radzan, T; Rain, AN; Sajiri, S | 1 |
| Andrade, FS; Baldeviano, GC; C P Lopes, S; Escobedo-Vargas, KS; Guerra, MGVB; Kobylinski, KC; Lacerda, MVG; López-Sifuentes, VM; Melo, GC; Monteiro, WM; Orfanó, AS; Pimenta, PFP; Pinilla, YT; S Sampaio, V; Secundino, NFC; Stoops, CA; Tarning, J; Vasquez, GM | 1 |
| Şimşek Yavuz, S; Ünal, S | 1 |
| Bandi, C; Corbett, Y; Epis, S; Nodari, R; Porretta, D; Taramelli, D; Varotto-Boccazzi, I | 1 |
| Anastasiou, IA; Eleftheriadou, I; Tentolouris, A; Tentolouris, N; Tsilingiris, D | 1 |
| Perišić, O | 1 |
| González-Cuevas, R; Ortega-Peña, M | 1 |
| Mishra, SK; Tripathi, T | 1 |
| Kumar, D; Trivedi, N; Verma, A | 1 |
| Wen, S; Xu, X; Yadav, AK; Yu, L | 1 |
| Araújo, AMM; Araújo, JV; Asato, MS; Buttenbender, SF; Carbonell, RCC; da Fonseca, AJ; Da Rocha, JG; de Andrade, SB; de Lima Moreira, A; de Sousa Resende, J; de Souza, RGS; Galan, LEB; Marques, FSS; Paiva, ADP; Portella, DGS; Santos, NMD; Santos, PL; Silva, GMA; Tizolim, MR | 1 |
| Chandra, PP; Jain, S; Potschka, H; Tripathi, M; Vohora, D | 1 |
| Rein, T | 1 |
| Fontinha, D; Francisco, D; Prudêncio, M; Singh, K; Singh, L | 1 |
| Bhardwaj, M; Chiu, MN; Sah, SP | 1 |
| Boretti, A | 1 |
| Correa, MB; Demarco, FF; Lima, GS; Martins-Filho, PR; Moraes, RR | 1 |
| Alsmadi, MM | 1 |
| Giarolla, J; Parise-Filho, R; Polli, MC; Vassiliades, SV; Vaz, ES | 1 |
10 review(s) available for chloroquine and dextrothyroxine
| Article | Year |
|---|---|
Antiviral treatment of COVID-19
Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Humans; Hydroxychloroquine; Ivermectin; Lopinavir; Nitro Compounds; Pandemics; Pneumonia, Viral; Pyrazines; Ritonavir; SARS-CoV-2; Thiazoles | 2020 |
Familiar Dermatologic Drugs as Therapies for COVID-19.
Topics: Androgen Antagonists; Antimalarials; Antioxidants; Antiparasitic Agents; Chloroquine; Cinchona; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Ivermectin; Melatonin; SARS-CoV-2; Virus Internalization | 2021 |
One year update on the COVID-19 pandemic: Where are we now?
Topics: Adenosine Monophosphate; Alanine; Amides; Animals; Antiviral Agents; Chloroquine; Clinical Trials as Topic; Coronavirus; Coronavirus Infections; COVID-19; COVID-19 Vaccines; Drug Combinations; Drug Repositioning; Glucocorticoids; Humans; Hydroxychloroquine; Indoles; Ivermectin; Lopinavir; Mutation; Pandemics; Phytotherapy; Plant Extracts; Pyrazines; Ritonavir; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Tinospora; Viral Zoonoses | 2021 |
Possible treatment and strategies for COVID-19: review and assessment.
Topics: Adenosine Monophosphate; Alanine; Amides; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antibodies, Neutralizing; Antiparasitic Agents; Antiviral Agents; Cannabinoids; Chloroquine; Complement Inactivating Agents; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; COVID-19 Vaccines; Dexamethasone; Drug Combinations; Enzyme Inhibitors; Humans; Hydroxychloroquine; Immunization, Passive; Indoles; Interferons; Ivermectin; Lopinavir; Nitro Compounds; Pyrazines; Ritonavir; SARS-CoV-2; Teicoplanin; Tetracyclines; Thiazoles | 2020 |
Antiviral treatment in COVID-19: which is the most promising?-a narrative review.
Topics: Adenosine Monophosphate; Alanine; Amides; Antibodies, Monoclonal, Humanized; Antiviral Agents; Azetidines; Chloroquine; COVID-19; COVID-19 Serotherapy; Drug Combinations; Humans; Hydroxychloroquine; Immunization, Passive; Indoles; Interferons; Ivermectin; Lopinavir; Nitro Compounds; Oseltamivir; Purines; Pyrazines; Pyrazoles; Ribavirin; Ritonavir; Sulfonamides; Thiazoles | 2021 |
Management of COVID-19 in patients with seizures: Mechanisms of action of potential COVID-19 drug treatments and consideration for potential drug-drug interactions with anti-seizure medications.
Topics: Adenosine Monophosphate; Alanine; Amides; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Anticonvulsants; Antiviral Agents; Chloroquine; COVID-19; COVID-19 Drug Treatment; Cytochrome P-450 CYP3A Inducers; Dexamethasone; Drug Combinations; Drug Interactions; Enzyme Inhibitors; Epilepsy; Glucocorticoids; Humans; Hydroxychloroquine; Interleukin 1 Receptor Antagonist Protein; Ivermectin; Lopinavir; Pyrazines; Ritonavir; SARS-CoV-2 | 2021 |
Harnessing autophagy to fight SARS-CoV-2: An update in view of recent drug development efforts.
Topics: Antidepressive Agents; Antiviral Agents; Artesunate; Autophagy; Chloroquine; COVID-19 Drug Treatment; Drug Development; Drug Repositioning; Endoplasmic Reticulum; Endosomes; Humans; Hydroxychloroquine; Imatinib Mesylate; Infliximab; Intracellular Membranes; Ivermectin; Macrolides; Middle East Respiratory Syndrome Coronavirus; Niclosamide; Pandemics; RNA, Viral; SARS-CoV-2; Virus Replication | 2022 |
Safety profile of COVID-19 drugs in a real clinical setting.
Topics: Antiviral Agents; Chloroquine; COVID-19 Drug Treatment; Dexamethasone; Drug-Related Side Effects and Adverse Reactions; Humans; Hydroxychloroquine; Ivermectin; Lopinavir; Reproducibility of Results; Ritonavir; SARS-CoV-2 | 2022 |
Zinc augments the antiviral potential of HCQ/CQ and ivermectin to reduce the risks of more serious outcomes from COVID-19 infection.
Topics: Antiviral Agents; Chloroquine; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Ivermectin; SARS-CoV-2; Treatment Outcome; Zinc | 2022 |
Drug repositioning in the COVID-19 pandemic: fundamentals, synthetic routes, and overview of clinical studies.
Topics: Antiviral Agents; Azithromycin; Chloroquine; COVID-19; Dexamethasone; Drug Repositioning; Humans; Hydroxychloroquine; Ivermectin; Methylprednisolone; Pandemics; Reproducibility of Results; SARS-CoV-2 | 2023 |
1 trial(s) available for chloroquine and dextrothyroxine
| Article | Year |
|---|---|
Phase 2 randomized study on chloroquine, hydroxychloroquine or ivermectin in hospitalized patients with severe manifestations of SARS-CoV-2 infection.
Topics: Adult; Aged; Antimalarials; Antiparasitic Agents; Chloroquine; COVID-19; COVID-19 Drug Treatment; Double-Blind Method; Female; Humans; Hydroxychloroquine; Inpatients; Ivermectin; Male; Middle Aged | 2021 |
10 other study(ies) available for chloroquine and dextrothyroxine
| Article | Year |
|---|---|
Clinical pharmacology looks at tropical medicine.
Topics: Amodiaquine; Anthelmintics; Antimalarials; Chloroquine; Diethylcarbamazine; Filariasis; Filaricides; Humans; Ivermectin; Malaria; Primaquine | 1987 |
[Ovine coccidiosis and its treatment under conditions of a livestock market in Senegal].
Topics: Animals; Antiprotozoal Agents; Chloroquine; Coccidiosis; Feces; Ivermectin; Lactones; Parasite Egg Count; Senegal; Sheep; Sheep Diseases | 1985 |
In vitro drug susceptibility of Acanthamoeba castellani to chloroquine, ivermectin and fungizon.
Topics: Acanthamoeba; Amebicides; Amphotericin B; Animals; Anti-Bacterial Agents; Chloroquine; Drug Evaluation, Preclinical; Drug Resistance; Ivermectin; Time Factors | 1996 |
Promising approach to reducing Malaria transmission by ivermectin: Sporontocidal effect against Plasmodium vivax in the South American vectors Anopheles aquasalis and Anopheles darlingi.
Topics: Animals; Anopheles; Brazil; Chloroquine; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Insect Vectors; Ivermectin; Malaria; Oocysts; Plasmodium vivax; Primaquine | 2018 |
Effects of combined drug treatments on Plasmodium falciparum: In vitro assays with doxycycline, ivermectin and efflux pump inhibitors.
Topics: Antimalarials; Chloroquine; Doxycycline; Drug Resistance; Drug Therapy, Combination; Humans; Ivermectin; Malaria, Falciparum; Plasmodium falciparum | 2020 |
In Vitro Data of Current Therapies for SARS-CoV-2.
Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; China; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Emetine; Homoharringtonine; Humans; Hydroxychloroquine; Ivermectin; Lopinavir; Nitro Compounds; Pandemics; Pneumonia, Viral; SARS-CoV-2; Teicoplanin; Thiazoles | 2020 |
Recognition of Potential COVID-19 Drug Treatments through the Study of Existing Protein-Drug and Protein-Protein Structures: An Analysis of Kinetically Active Residues.
Topics: Adenosine Monophosphate; Alanine; Angiotensin-Converting Enzyme 2; Antibodies, Viral; Antigen-Antibody Reactions; Antiviral Agents; Betacoronavirus; Binding Sites; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Eflornithine; Humans; Hydrophobic and Hydrophilic Interactions; Ivermectin; L-Lactate Dehydrogenase; Models, Molecular; Molecular Docking Simulation; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Proline; Protein Binding; Protein Conformation; Protein Interaction Mapping; Receptors, Glycine; Saposins; SARS-CoV-2; Sofosbuvir; Spike Glycoprotein, Coronavirus; Structure-Activity Relationship | 2020 |
Synthesis and antiplasmodial activity of regioisomers and epimers of second-generation dual acting ivermectin hybrids.
Topics: Antimalarials; Chloroquine; Isomerism; Ivermectin; Microbial Sensitivity Tests; Plasmodium berghei; Plasmodium falciparum | 2022 |
COVID-19 incidence, severity, medication use, and vaccination among dentists: survey during the second wave in Brazil.
Topics: Brazil; Chloroquine; COVID-19; COVID-19 Vaccines; Cross-Sectional Studies; Dentists; Humans; Incidence; Ivermectin; Pandemics; SARS-CoV-2; Surveys and Questionnaires; Vaccination; Vaccines; Vitamin D; Zinc | 2022 |
The investigation of the complex population-drug-drug interaction between ritonavir-boosted lopinavir and chloroquine or ivermectin using physiologically-based pharmacokinetic modeling.
Topics: Adult; Chloroquine; COVID-19; COVID-19 Drug Treatment; Cytochrome P-450 CYP3A; Drug Interactions; Humans; Ivermectin; Lopinavir; Ritonavir | 2023 |